WebApr 10, 2024 · Gilead Sciences (GILD-0.07%) is a top HIV treatment company that has a bright future ahead. But in the past decade, it's been a bit of a bumpy ride for the business as its top line hasn't always ... WebApr 10, 2024 · About Gilead Sciences Inc. Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of …
Gilead Sciences, Inc. (GILD) - Yahoo Finance
WebJan 31, 2024 · At first glance, this description fits Gilead Sciences (GILD-0.34%), one of the largest biotechs in the world with a forward price-to-earnings (P/E) ratio of 10, compared to the industry's average ... WebThe projected annual revenue for Gilead Sciences is $26,046MM, a decrease of 4.53%. The projected annual non-GAAP EPS is $6.89. For more in-depth coverage of Gilead Sciences, view the free, crowd ... ranch houses in new jersey
7 Things You Didn
Web1 day ago · Gilead Sciences (GILD) closed at $82.16 in the latest trading session, marking a -0.46% move from the prior day. This change lagged the S&P 500's 0.41% loss on the … WebSep 1, 2024 · Gilead Sciences (NASDAQ:GILD) has an almost $80 billion market capitalization, but the company remains well below its highs that it set roughly 7 years ago during the craze over the potential of ... WebApr 11, 2024 · According to the issued ratings of 17 analysts in the last year, the consensus rating for Gilead Sciences stock is Hold based on the current 9 hold ratings and 8 buy ratings for GILD. The average twelve-month price prediction for Gilead Sciences is $89.40 with a high price target of $112.00 and a low price target of $70.00. ranch houses in nevada